V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002283 | 210005867 | 1.63 | 48.2 | Adjuvant (A) | null | 2016-02-19 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101747615 |
| 210002284 | 210005868 | 1.68 | 85.8 | Adjuvant (A) | 2016-08-27 | 2016-09-11 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100680766 |
| 210002285 | 210005869 | null | null | Neo-adjuvant (N) | 2019-04-21 | 2019-05-09 | Docetaxel | null | null | DOCETAXEL | 100327167 |
| 210002286 | 210005870 | null | 73.2 | null | 2018-07-12 | 2018-07-25 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101122143 |
| 210002287 | 210005871 | 1.6 | 50.6 | Palliative (P) | 2017-04-19 | 2017-04-25 | Docetaxel | 02 | N | DOCETAXEL | 100583150 |
| 210002288 | 210005872 | 1.63 | 79.6 | Adjuvant (A) | 2017-10-12 | 2017-10-30 | Docetaxel | 02 | N | DOCETAXEL | 100591308 |
| 210002289 | 210005873 | 1.61 | 87.6 | Curative (C) | null | 2019-01-06 | PACLITAXEL | 02 | null | PACLITAXEL | 100369860 |
| 210002290 | 210005874 | null | 60 | null | 2018-11-22 | 2018-11-30 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100735481 |
| 210002292 | 210005876 | 1.63 | 68.9 | Adjuvant (A) | null | 2019-07-11 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101168181 |
| 210002293 | 210005877 | 1.63 | 70.5 | Neo-adjuvant (N) | null | 2018-11-07 | Paclitaxel (2 or 3 weekly) | 02 | N | PACLITAXEL | 101590197 |
| 210002294 | 210005878 | 1.55 | 66 | Adjuvant (A) | 2017-02-06 | 2017-02-06 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 100160753 |
| 210002295 | 210005879 | 1.52 | 71.2 | Adjuvant (A) | null | 2019-08-24 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100688066 |
| 210002298 | 210005881 | 1.67 | 96.1 | Adjuvant (A) | 2016-11-15 | 2016-11-26 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101783298 |
| 210002299 | 210005882 | 1.71 | 74.2 | Adjuvant (A) | 2018-12-06 | 2018-12-07 | Trastuzumab Subcutaneous | 99 | N | TRASTUZUMAB | 101087745 |
| 210002302 | 210005883 | null | 78.2 | Adjuvant (A) | 2018-05-21 | 2018-06-05 | PACLITAXEL | 02 | null | PACLITAXEL | 101777670 |
| 210002303 | 210005884 | 1.56 | 88.1 | Adjuvant (A) | 2016-03-12 | 2016-03-26 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100081906 |
| 210002306 | 210005885 | 1.66 | 106.8 | null | 2016-07-08 | 2016-07-08 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100851062 |
| 210002308 | 210005887 | null | null | null | 2018-10-20 | 2018-11-15 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101531795 |
| 210002309 | 210005888 | 1.6 | 88.8 | Palliative (P) | 2019-11-16 | 2019-12-03 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | PACLITAXEL | 101069839 |
| 210002311 | 210005890 | 1.61 | 93.8 | Adjuvant (A) | 2019-08-13 | 2019-08-28 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100874153 |
| 210002313 | 210005891 | 1.63 | 67 | Palliative (P) | 2017-07-07 | 2017-07-15 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100759581 |
| 210002319 | 210005895 | 1.58 | 87.6 | Adjuvant (A) | 2018-11-08 | 2018-11-22 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101581269 |
| 210002320 | 210005896 | null | 68.6 | null | 2018-07-11 | 2018-07-25 | Docetaxel | null | null | DOCETAXEL | 101163408 |
| 210002325 | 210005901 | 1.7 | 72.3 | Adjuvant (A) | 2019-02-03 | 2019-02-04 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100993723 |
| 210002326 | 210005902 | null | null | null | 2016-12-24 | 2017-01-12 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 100710065 |
| 210002327 | 210005903 | 1.55 | 72.4 | null | null | 2018-01-13 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100688724 |
| 210002329 | 210005904 | 1.65 | 63.5 | Adjuvant (A) | null | 2016-06-25 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101024370 |
| 210002333 | 210005907 | null | 43.2 | null | 2017-06-02 | 2017-06-11 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100259113 |
| 210002334 | 210005908 | 1.48 | 69.3 | Adjuvant (A) | 2017-01-06 | 2017-01-13 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100728878 |
| 210002335 | 210005909 | 1.77 | 0 | Adjuvant (A) | 2016-11-27 | 2016-12-12 | Paclitaxel 7 day | null | N | PACLITAXEL | 101185242 |
| 210002337 | 210005910 | 1.53 | 57 | Adjuvant (A) | 2020-03-04 | 2020-03-20 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101780891 |
| 210002338 | 210005911 | null | 69 | null | null | 2018-02-20 | Docetaxel | 02 | null | DOCETAXEL | 101336056 |
| 210002340 | 210005912 | 1.76 | 58.5 | Adjuvant (A) | 2017-05-14 | 2018-12-11 | Trastuzumab | 02 | N | TRASTUZUMAB | 101000180 |
| 210002341 | 210005913 | 1.63 | 56.6 | Adjuvant (A) | 2017-07-02 | 2017-07-24 | Docetaxel | null | N | DOCETAXEL | 100030264 |
| 210002342 | 210005914 | 1.64 | 89 | Neo-adjuvant (N) | 2016-03-07 | 2018-07-03 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100149741 |
| 210002344 | 210005916 | 1.57 | 89.4 | Adjuvant (A) | 2018-03-09 | 2018-03-25 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100834406 |
| 210002345 | 210005917 | 1.7 | 70 | Adjuvant (A) | 2016-10-27 | 2016-11-13 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100080358 |
| 210002346 | 210005918 | null | null | null | 2017-12-08 | 2017-12-16 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100302717 |
| 210002348 | 210005919 | null | 74.55 | null | 2018-11-01 | 2019-01-31 | Docetaxel | 01 | null | DOCETAXEL | 101239949 |
| 210002351 | 210005921 | 1.73 | 79.85 | Adjuvant (A) | 2016-08-12 | 2016-08-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101653611 |
| 210002352 | 210005922 | 1.71 | 88.8 | Adjuvant (A) | null | 2016-10-27 | Docetaxel | 02 | null | DOCETAXEL | 100828899 |
| 210002353 | 210005923 | 1.62 | 70.2 | Palliative (P) | 2018-08-05 | 2018-08-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100062282 |
| 210002355 | 210005924 | 1.67 | 0 | Adjuvant (A) | 2018-08-29 | 2018-09-11 | Docetaxel | 02 | N | DOCETAXEL | 100617399 |
| 210002356 | 210005925 | 1.57 | 77.6 | Palliative (P) | null | 2019-11-15 | Docetaxel | 02 | N | DOCETAXEL | 100612832 |
| 210002357 | 210005926 | 1.56 | 108 | Neo-adjuvant (N) | 2019-01-03 | 2019-01-04 | Trastuzumab | 02 | null | TRASTUZUMAB | 101511643 |
| 210002358 | 210005927 | 1.77 | 75.4 | Adjuvant (A) | 2013-01-25 | 2013-02-14 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100651139 |
| 210002359 | 210005928 | 1.47 | 81 | Adjuvant (A) | 2017-04-12 | 2017-04-13 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100465847 |
| 210002360 | 210005929 | 1.56 | 64 | Adjuvant (A) | 2018-06-08 | 2018-06-23 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100012837 |
| 210002362 | 210005930 | 1.67 | 63 | Neo-adjuvant (N) | 2020-12-25 | 2020-12-25 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100908757 |
| 210002363 | 210005931 | 1.62 | 47 | Adjuvant (A) | null | 2018-05-07 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101304943 |